Cardiovascular Agents - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Therapeutic options and patterns of prescription in chronic venous disorders: results of a 3-year survey in Italy.

29 Sep 2009 OBJECTIVES: To assess self-management of chronic venous disorders (CVDs) in a selected Italian population and the pattern of prescription by selected Italian phlebologists. DESIGN: Cross-sectional study carried out between 2003 and 2005. MATERIALS: ... Read more...

Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.

27 Sep 2009 OBJECTIVES: Our aim was to access clinical effectiveness of percutaneous coronary intervention (PCI) when added to optimal medical therapy (OMT) in older patients with stable coronary artery disease (CAD). BACKGROUND: While older patients with CAD ... Read more...

Microvascular oxygen delivery-to-utilization mismatch at the onset of heavy-intensity exercise in optimally treated patients with CHF.

2 Sep 2009 Impaired muscle blood flow at the onset of heavy-intensity exercise may transiently reduce microvascular O(2) pressure and decrease the rate of O(2) transfer from capillary to mitochondria in chronic heart failure (CHF). However, advances in the ... Read more...

Latest indexed articles for 'Cardiovascular Agents - Therapeutic use'

These are the very latest articles for this heading:

• Recurrence of local anesthetic cardiac toxicity or hypokalemia? 30 Oct 2009
• Generic drugs revisited. 17 Oct 2009
• Therapeutic options and patterns of prescription in chronic venous disorders: results of a 3-year survey in Italy. 29 Sep 2009
• Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. 27 Sep 2009
• Microvascular oxygen delivery-to-utilization mismatch at the onset of heavy-intensity exercise in optimally treated patients with CHF. 2 Sep 2009
• [Chronic coronary heart disease. Family practice therapy is restored] Sep 2009
• Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients. 30 Aug 2009
• Cognitive decline after invasive intervention in cardiovascular disease: is it drug related? 30 Aug 2009
• Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. 30 Aug 2009
• [Controversies in hypertrophic cardiomyopathy] 30 Aug 2009
• Heart failure in children: part II: diagnosis, treatment, and future directions. 30 Aug 2009
• Overview of emerging pharmacotherapy in chronic heart failure. 30 Aug 2009
• Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years. 30 Aug 2009
• How to improve cardiovascular diseases prevention in Europe? 30 Aug 2009
• Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 30 Aug 2009
• Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care. 30 Aug 2009
• Evaluating patients with persistent chest pain and no obstructive coronary artery disease. 10 Aug 2009
• [How to evaluate and treat heart failure with preserved left ventricular ejection fraction] 9 Aug 2009
• Calcium channel blocker toxicity. 30 Jul 2009
• Practical barriers to the implementation of early goal directed therapy in the UK: trainee skills and awareness. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Cardiovascular Agents'

Definition: Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.

Registry Number: 0

Descriptor UI: D002317

Alternative terms: Cardiovascular Agents; Agents, Cardiovascular; Cardiovascular Drugs; Drugs, Cardiovascular;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411;

Online Note: consider also CARDIOVASCULAR SYSTEM /DE

History Note: 79; was NON MESH before 1979